New imaging probe tested during bladder tumour removal surgery
Tests a new imaging catheter in adults having bladder tumour removal surgery.
Key facts
- Who runs it
- Amsterdam UMC
- Where
- Amsterdam, NetherlandsSee the site
- Trial code
- Registry title
- Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment
- Status
- Recruiting
- People taking part
- 15 people, planned
- Started
- Dec 2024
- Planned end
- Apr 2025
- Type of study
- Interventional
- Treatments tested
- Optical coherence tomography
- Record updated
- 6 December 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have a suspected bladder tumour and are having it removed through the urethra (TURBT). A new imaging probe is used during the operation.
- Age
- Older than 18 years.
- Sex
- All sexes can join.
- Disease stage
- At least 1 suspected bladder tumour seen at cystoscopy, in a bladder that can be examined with a cystoscope.
Main reasons for not taking part
- Pregnant or breastfeeding women
- The only tumour is at the bladder neck
- Tumour larger than 2 centimetres (0.8 in) in diameter
- More than 5 tumours
- Only a suspected flat lesion
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Age > 18 years
- Have at least 1 suspected bladder tumour seen at cystoscopy
- Have a bladder that is accessible for cystoscopy
- Be in a physical condition to undergo a TURBT
- Eligible patients must be fully informed about the study and written signed informed consent must be obtained prior to any study related investigation/intervention
Who cannot take part
- Pregnant or lactating women
- The only tumour site is at the bladder neck
- The tumour(s) is larger than 2 centimetres in diameter
- >5 tumours present
- Solely a suspected flat lesion present
Where in Netherlands
- Amsterdam University Medical CenterAmsterdam, NetherlandsContact: Marinka Remmelink, MDNot yet recruiting
About the trial
What the trial wants to find out
The goal of this clinical trial is to see if a new designed optical coherence tomography catheter can be used in bladder cancer in patients undergoing a transurethral resection of a bladder tumour. The main question it aims to answer is:
Read full original descriptionShow less
- Is the optical coherence tomography catheter feasible in capturing images of bladder tumours and normal bladder wall during a transurethral resection of a bladder tumour?
Participants will undergo measurements with a new optical coherence tomography device during the transurethral resection of their bladder tumour(s).
The group in the trial
- Optical coherence tomography measurements during transurethral resection of a bladder tumourOther group
Single arm
Treatment: Optical coherence tomography
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- IDEAL Phase II Study of a Newly Designed Optical Coherence Tomography Probe During Transurethral Resection for Optimizing Bladder Cancer Diagnosis and Treatment
- Plain-language title
- New imaging probe tested during bladder tumour removal surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Record updated
- 6 December 2024